Search research articles
Contact Us
Filters
Showing results (71-80 of 85) with videos related to
Page
of 9
Sort By:
The Annals of Thoracic Surgery
|
August 2, 2011
Circulating fibrocytes correlate with bronchiolitis obliterans syndrome development after lung transplantation: a novel clinical biomarker
Damien J LaPar, Marie D Burdick, Abbas Emaminia, et al.
The American Journal of Pathology
|
October 9, 2002
The role of MIG/CXCL9 in cardiac allograft vasculopathy
James J Yun, Michael P Fischbein, David Whiting, et al.
International Journal of Cancer
|
May 12, 2009
CXC-chemokine/CXCR2 biological axis promotes angiogenesis in vitro and in vivo in pancreatic cancer
Yoichi Matsuo, Massimo Raimondo, Timothy A Woodward, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 22, 2003
Role of CXCL9/CXCR3 chemokine biology during pathogenesis of acute lung allograft rejection
John A Belperio, Michael P Keane, Marie D Burdick, et al.
Blood
|
October 29, 2010
Angiostatic and chemotactic activities of the CXC chemokine CXCL4L1 (platelet factor-4 variant) are mediated by CXCR3
Sofie Struyf, Laura Salogni, Marie D Burdick, et al.
Cancer Research
|
December 17, 2005
Activation of tumor-associated macrophages by the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid induces an effective CD8+ T-cell-mediated antitumor immune response in murine models of lung cancer and mesothelioma
Arminder S Jassar, Eiji Suzuki, Veena Kapoor, et al.
Plos One
|
July 7, 2011
Plasma chemokine levels are associated with the presence and extent of angiographic coronary collaterals in chronic ischemic heart disease
Ellen C Keeley, J Randall Moorman, Ling Liu, et al.
The Journal of Clinical Investigation
|
April 3, 2002
IL-7 inhibits fibroblast TGF-beta production and signaling in pulmonary fibrosis
Min Huang, Sherven Sharma, Li X Zhu, et al.
The Journal of Clinical Investigation
|
May 3, 2005
Role of CXCR2/CXCR2 ligands in vascular remodeling during bronchiolitis obliterans syndrome
John A Belperio, Michael P Keane, Marie D Burdick, et al.
Cancer Research
|
November 19, 2004
BRAK/CXCL14 is a potent inhibitor of angiogenesis and a chemotactic factor for immature dendritic cells
Thomas D Shellenberger, Mary Wang, Manu Gujrati, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 85) with videos related to
Sort By:
Page
of 9
The Annals of Thoracic Surgery
|
August 2, 2011
Circulating fibrocytes correlate with bronchiolitis obliterans syndrome development after lung transplantation: a novel clinical biomarker
Damien J LaPar, Marie D Burdick, Abbas Emaminia, et al.
The American Journal of Pathology
|
October 9, 2002
The role of MIG/CXCL9 in cardiac allograft vasculopathy
James J Yun, Michael P Fischbein, David Whiting, et al.
International Journal of Cancer
|
May 12, 2009
CXC-chemokine/CXCR2 biological axis promotes angiogenesis in vitro and in vivo in pancreatic cancer
Yoichi Matsuo, Massimo Raimondo, Timothy A Woodward, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 22, 2003
Role of CXCL9/CXCR3 chemokine biology during pathogenesis of acute lung allograft rejection
John A Belperio, Michael P Keane, Marie D Burdick, et al.
Blood
|
October 29, 2010
Angiostatic and chemotactic activities of the CXC chemokine CXCL4L1 (platelet factor-4 variant) are mediated by CXCR3
Sofie Struyf, Laura Salogni, Marie D Burdick, et al.
Cancer Research
|
December 17, 2005
Activation of tumor-associated macrophages by the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid induces an effective CD8+ T-cell-mediated antitumor immune response in murine models of lung cancer and mesothelioma
Arminder S Jassar, Eiji Suzuki, Veena Kapoor, et al.
Plos One
|
July 7, 2011
Plasma chemokine levels are associated with the presence and extent of angiographic coronary collaterals in chronic ischemic heart disease
Ellen C Keeley, J Randall Moorman, Ling Liu, et al.
The Journal of Clinical Investigation
|
April 3, 2002
IL-7 inhibits fibroblast TGF-beta production and signaling in pulmonary fibrosis
Min Huang, Sherven Sharma, Li X Zhu, et al.
The Journal of Clinical Investigation
|
May 3, 2005
Role of CXCR2/CXCR2 ligands in vascular remodeling during bronchiolitis obliterans syndrome
John A Belperio, Michael P Keane, Marie D Burdick, et al.
Cancer Research
|
November 19, 2004
BRAK/CXCL14 is a potent inhibitor of angiogenesis and a chemotactic factor for immature dendritic cells
Thomas D Shellenberger, Mary Wang, Manu Gujrati, et al.
Page
of 9